Blue Trust’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
Blue Trust's RNTX Position: Q3 2026 in Review
Blue Trust held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 20 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #2501.
Blue Trust first reported a position in RNTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $35 in Q1 2025. 48 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.
- Blue Trust held 20 shares of Rein Therapeutics worth $16 as of Q3 2026.
- Blue Trust left its Rein Therapeutics share count unchanged in Q3 2026.
- Rein Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2501 holding.
- Blue Trust first reported a position in Rein Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Blue Trust's Rein Therapeutics position peaked at $35 in Q1 2025.
- 48 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.